Biomind Labs (NEOE:BMND) COGS-to-Revenue : 0.00 (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Biomind Labs COGS-to-Revenue?

Biomind Labs's Cost of Goods Sold for the three months ended in Sep. 2024 was C$0.00 Mil. Its Revenue for the three months ended in Sep. 2024 was C$0.00 Mil.

Biomind Labs's COGS to Revenue for the three months ended in Sep. 2024 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Biomind Labs's Gross Margin % for the three months ended in Sep. 2024 was N/A%.

Biomind Labs COGS-to-Revenue Historical Data

The historical data trend for Biomind Labs's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomind Labs COGS-to-Revenue Chart

Biomind Labs Annual Data

Trend

Dec21

Dec22

Dec23

COGS-to-Revenue

Biomind Labs Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
COGS-to-Revenue	Get a 7-Day Free Trial										-	-	-	-	-

Biomind Labs COGS-to-Revenue Calculation

Biomind Labs's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Biomind Labs's COGS to Revenue for the quarter that ended in Sep. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Biomind Labs (NEOE:BMND) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Biomind Labs's Gross Margin % for the three months ended in Sep. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Biomind Labs COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Biomind Labs's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomind Labs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomind Labs Inc (NEOE:BMND) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

BMNDF:USA 3XI:Germany

Address

Camino Saravia s/n, Pando Science and Technology Park, Pando Canelones, Canelones, URY, CP 91.000

Website

https://www.biomindlabs.com

Biomind Labs Inc is a biotech Research and Development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Biomind is developing pharmaceutical sole and combined formulations of the main natural psychedelic molecules with the aim of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.

Biomind Labs Headlines

No Headlines